If YAP activation inhibits ccRCC cell growth in 2D cultures by impeding p65/ZHX2 cooperativity, one would predict that increasing the level of either ZHX2 or p65 may rescue ccRCC cell growth inhibited by XMU-MP-1. The gene discussed is ZHX2; the disease is nonpapillary renal cell carcinoma.